DAAM1 inhibitors belong to a distinctive chemical class that primarily targets the Diaphanous-related formin-1 (DAAM1) protein. DAAM1, a member of the formin family, plays a crucial role in regulating the dynamics of actin cytoskeleton assembly and organization. Actin cytoskeleton dynamics are integral to various cellular processes, including cell motility, shape determination, and intracellular transport. The DAAM1 protein, specifically, functions as an actin nucleator and modulates the formation of actin filaments, which are essential for maintaining cellular structure and facilitating cellular movements. In this context, DAAM1 inhibitors are designed to selectively hinder the catalytic activity of DAAM1, thereby disrupting the normal actin cytoskeleton dynamics.
The chemical structure of DAAM1 inhibitors is characterized by specific pharmacophores and molecular motifs that interact with the active site of the DAAM1 protein. These inhibitors are meticulously designed to bind to key regions of the protein, inhibiting its nucleation activity and impeding the elongation of actin filaments. The rationale behind developing DAAM1 inhibitors lies in the potential modulation of cellular functions that rely on dynamic actin cytoskeleton rearrangements. The specificity of these inhibitors for DAAM1 distinguishes them from other compounds targeting the broader formin family, underlining their potential as research tools for dissecting the precise cellular functions governed by DAAM1-mediated actin dynamics. As a result, the study and development of DAAM1 inhibitors contribute to a deeper understanding of the intricate regulatory mechanisms governing cellular morphology and motility.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Targets tankyrase, leading to stabilization of Axin and inhibition of the Wnt/β-catenin pathway, which is connected to DAAM1 function. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibits Wnt production, thereby decreasing the Wnt signaling that activates DAAM1. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
Promotes degradation of β-catenin, a component of the Wnt pathway, potentially downregulating DAAM1 activity. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $352.00 $1270.00 | 2 | |
Inhibits Wnt ligand secretion, therefore reducing DAAM1 activation downstream of Wnt signaling. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $178.00 $367.00 | 7 | |
Inhibits both Wnt/β-catenin and peroxisome proliferator-activated receptor signaling, potentially affecting DAAM1. | ||||||
PNU-74654 | 113906-27-7 | sc-258020 sc-258020A | 5 mg 25 mg | $128.00 $485.00 | 7 | |
Disrupts Wnt/β-catenin signaling by blocking the interaction between β-catenin and TCF4, potentially affecting DAAM1 function. | ||||||
PKF118-310 | 84-82-2 | sc-364590 sc-364590A | 5 mg 25 mg | $176.00 $638.00 | ||
TCF/β-catenin complex inhibitor, possibly affecting downstream DAAM1 activity. | ||||||
Cercosporin | 35082-49-6 | sc-255013 | 5 mg | $450.00 | 1 | |
Inhibits Wnt/β-catenin pathway by binding to TCF, possibly influencing DAAM1 activity. | ||||||